Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention GuidelinesJeremy Brown, Neal Sikka, Robert Shesser et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2007Cited by 169
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) StudyCassidy A. Gutner, Maggie Czarnogorski, Annemiek de Ruiter et al.|Journal of the International Association of Providers of AIDS Care (JIAPAC)|2024Cited by 14
Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI studyKatherine Nelson, Nanlesta Pilgrim, Yolanda Lawson et al.|Journal of the International AIDS Society|2025Cited by 4
CD4 Counts in Patients Diagnosed With HIV Through Routine HIV Screening in Two Urban Emergency DepartmentsJeremy Brown, Vanessa Lee, Douglas A.E. White et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2010Cited by 1
1559. Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis into Standard of Care: Baseline Results from the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR)Julian A Torres, Nanlesta Pilgrim, Dima Dandachi et al.|Open Forum Infectious Diseases|2023Cited by 0